OPEN LABEL EVALUATION OF THE NOVEL ANTIPSYCHOTIC COMPOUND BW234U IN CHRONIC-SCHIZOPHRENICS

被引:31
作者
SCHWARCZ, G
HALARIS, A
DREN, A
MANBERG, P
机构
[1] CLEVELAND METROPOLITAN GEN HOSP,DEPT PSYCHIAT,3395 SCRANTON RD,CLEVELAND,OH 44109
[2] UNIV CALIF LOS ANGELES,VET ADM MED CTR BRENTWOOD,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90024
[3] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1002/ddr.430050412
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:387 / 393
页数:7
相关论文
共 3 条
[1]  
DAVIDSON J, 1982, Psychopharmacology Bulletin, V18, P173
[2]   BW234U, (CIS-9-[3-(3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE DIHYDROCHLORIDE) - A NOVEL ANTIPSYCHOTIC AGENT [J].
FERRIS, RM ;
HARFENIST, M ;
MCKENZIE, GM ;
COOPER, B ;
SOROKO, FE ;
MAXWELL, RA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (06) :388-390
[3]   PSYCHOTROPIC ACTIONS OF BW-234U IN THE TREATMENT OF INPATIENT SCHIZOPHRENICS - A DOSE-RANGE STUDY [J].
GUY, W ;
MANOV, G ;
WILSON, WH ;
BAN, TA ;
FJETLAND, OK ;
MANBERG, PJ ;
DREN, AT .
DRUG DEVELOPMENT RESEARCH, 1983, 3 (03) :245-252